Latest news
Entrada Reports Early Functional Benefit in Phase 1/2 Duchenne Study of ENTR-601-44 - BioPharm InternationalBioPharm International · Fri, 07 Aug 2026 19:52:06 GMTEntrada Therapeutics, Inc. (TRDA) stock price, news, quote and history - Yahoo Finance AustraliaYahoo Finance Australia · Thu, 06 Aug 2026 19:31:53 GMTEntrada Therapeutics Releases Q2 2026 Financial Results - AlphaStreetAlphaStreet · Wed, 05 Aug 2026 18:34:56 GMTEntrada Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.commarketscreener.com · Wed, 05 Aug 2026 13:38:55 GMTEntrada Therapeutics, Inc. reports results for the quarter ended June 30 - Earnings Summary - TradingViewTradingView · Wed, 05 Aug 2026 13:18:26 GMTEntrada Therapeutics, Inc. (TRDA) Reports Q2 Loss, Tops Revenue Estimates - Yahoo FinanceYahoo Finance · Wed, 05 Aug 2026 13:00:09 GMTEntrada Therapeutics, Inc. 2026: Revenue $898K, EPS ($1.01) — 10-Q Summary - TradingViewTradingView · Wed, 05 Aug 2026 11:21:02 GMTEntrada Therapeutics reports Q2 2026 results: $223.0M cash; Q2 net loss $42.8M - TradingViewTradingView · Wed, 05 Aug 2026 11:13:00 GMT